Douglas W. Pagán

2020

In 2020, Douglas W. Pagán earned a total compensation of $2.4M as Chief Financial Officer at Dicerna Pharmaceuticals.

Compensation breakdown

Bonus$100,000
Non-Equity Incentive Plan$162,000
Option Awards$1,357,274
Salary$243,000
Stock Awards$567,567
Other$10,648
Total$2,440,489

Pagán received $1.4M in option awards, accounting for 56% of the total pay in 2020.

Pagán also received $100K in bonus, $162K in non-equity incentive plan, $243K in salary, $567.6K in stock awards and $10.6K in other compensation.

Rankings

In 2020, Douglas W. Pagán's compensation ranked 4,662nd out of 13,090 executives tracked by ExecPay. In other words, Pagán earned more than 64.4% of executives.

ClassificationRankingPercentile
All
4,662
out of 13,090
64th
Division
Manufacturing
1,896
out of 5,618
66th
Major group
Chemicals And Allied Products
742
out of 2,251
67th
Industry group
Drugs
636
out of 1,951
67th
Industry
Pharmaceutical Preparations
480
out of 1,456
67th

Pay ratio

Douglas W. Pagán's Pay$2,440,489
Median Employee's Pay$311,375
Pay Ratio

8

to 1

In 2020, the annual total compensation of Douglas W. Pagán was $2,440,489.

The annual total compensation of the median employee at Dicerna Pharmaceuticals was $311,375.

The ratio of Douglas W. Pagán's pay to the pay of median employee was therefore 8 to one.

Source: SEC filing on April 20, 2021.

Pagán's colleagues

We found six more compensation records of executives who worked with Douglas W. Pagán at Dicerna Pharmaceuticals in 2020.

2020

Douglas Fambrough

Dicerna Pharmaceuticals

Chief Executive Officer

2020

Ralf Rosskamp

Dicerna Pharmaceuticals

Chief Medical Officer

2020

John Green

Dicerna Pharmaceuticals

Chief Financial Officer

2020

Bob Brown

Dicerna Pharmaceuticals

Chief Scientific Officer

2020

James Weissman

Dicerna Pharmaceuticals

Chief Operating Officer

2020

Shreeram Aradhye

Dicerna Pharmaceuticals

Chief Medical Officer

News

In-depth

You may also like